Español
Français

Program

Monday 6th March 2017


12.30-13.30. Registration and buffet lunch.


13.30-13:45. Welcome by Prof. Pablo Menendez

13.45-15.15. SESSION 1: An evolutionary perspective of cancer

Chairman: Prof. Ignacio Varela

Prof. David Posada – University of Vigo. Spain.
Tumor phylogeography

Prof. Andrea Sottoriva – Institute of Cancer Research, London. UK.
Neutral evolution in cancer: distinguishing functional from nonfunctional intra-tumour heterogeneity

Prof. Christina Curtis – Stanford University School of Medicine, California. USA.
Quantifying tumor evolutionary dynamics: from initiation to metastasis

15.15-15.45. Coffee Break

15.45-18.15. SESSION 2: Molecular diagnosis of intratumoral heterogeneity
Chairman: Prof. Pablo Menéndez

Prof. David Kent – University of Cambridge. UK.
Single cell biology identifies stem cell fate regulators in hematological malignancies

Prof. Caroline Dive – CRUK Manchester. UK.
New patient relevant models to study SCLC evolution, response to treatment and mechanisms of resistance

Prof. Nuria López-Bigas – University Pompeu Fabra, Barcelona. Spain.
Cancer drivers and their therapeutic opportunities

Prof. Sean Bendall- Deàrtment of Pathology Standford University.CA.USA. Single Cells Cues from Human Hematopoiesis to predict Acute leukemia.

18.15-18.30 Break

18.30-19.15 KEYNOTE LECTURE

Prof. Carlo Maley- School of Life Science, Arizona State University. USA.

20.30. SPEAKERS DINNER

 

Tuesday 7th March 2017

9.00-10.45. SESSION 3: Intratumour heterogeneity in hematopoietic malignancies

Chairman: Dra. Alejandra Sanjuan

Prof. John E Dick – Princess Margaret Centre, University health network,Toronto. Canada
Identifying the cellular origins of relapse in acute leukaemia

Prof. Eli Papaemmanuil – Memorial Sloan Kettering Cancer Center, New York. USA.
Dissecting genetic and phenotypic heterogeneity in AML

Prof. Xose A Puente. University of Oviedo. Spain.
Genomic architecture of chronic lymphocytic leukemia

10.45-11.15. Coffee Break

11.15-13.00. SESSION 4: Intratumour heterogeneity in solid tumours I

Chairman: Prof. Jaume Mora

Prof. Mario L Suvà – Harvard Medical School. Boston. USA.
Single-cell analyses in human gliomas

Prof. Chris Jones – Institute of Cancer Research, London. UK.   
Clonal co-operation in paediatric glioblastoma and DIPG

Prof. Marco Gerlinger – Institute of Cancer Research, London. UK.   
Reconstructing and forecasting solid tumour evolution

13.00-14.30. Lunch

14.30-16.30. SESSION 5: Intratumour heterogeneity in solid tumours II

Chairman: Prof Aleix Prat

Prof. Peter Dirks – Sick Children Hospital. University of Toronto. Canada
Tipping the balance of self-renewal and differentiation in brain cancer

Prof. Joan Seoane – Vall d’Hebron Oncology Institute, Barcelona. Spain.
Genomic intratumor heterogeneity and cancer resistance to treatment

Prof. Alberto Bardelli – Institute for Cancer Research and Treatment, Torino. Italy.
Cancer evolution as a therapeutic target

Prof. Eric Holland – Fred Hutch Hospital, Seattle. USA.
Visualization of the glioma landscape

16.30-17.00. Coffee Break

17.00-18.00. SESSION 6: ROUND TABLE: dealing with intratumour heterogeneity in the clinical practice.

Chairman: Prof Aleix Prat and Prof Pablo Menéndez

Prof. Nuria López-Bigas – UPF, Barcelona. Spain..

Prof. Peter Dirks – Sick Children Hospital, Toronto. Canada.

Prof. Eric Holland – Fred Hutch Hospital, Seattle. USA

Prof. Josep Tabernero - Vall d’Hebron Oncology Institute, Barcelona. Spain.

Prof. John E. Dick- Princess Margaret Centre, University health network, Toronto. Canada

18.00-18.10. Closing by Prof. Tabernero. Vall d’Hebron Oncology Institute, Barcelona. Spain.

18:.10-18.15. Farewell and departure

Prof. Antonio Huerta-Director of ICREA

Antoni García-Prat.Managing Director FIJC